Summary
Global Pediatric Allergy Diagnostics Market was valued at USD 2.32 Billion in 2023 and is expected to reach USD 4.01 Billion by 2029 with a CAGR of 9.72% during the forecast period.
The Global Pediatric Allergy Diagnostics Market has witnessed significant growth due to the rising prevalence of allergic conditions among children, including food allergies, respiratory allergies, and atopic dermatitis. Increasing awareness of allergic diseases and advancements in diagnostic technologies, such as skin prick tests, specific IgE tests, and component-resolved diagnostics, have contributed to market expansion. According to the 2021 National Health Interview Survey (NHIS) conducted by the National Center for Health Statistics (NCHS), a division of the Centers for Disease Control and Prevention (CDC), 5.8% of children aged 0 to 17 have been diagnosed with a food allergy. Healthcare providers are increasingly adopting innovative diagnostic tools to ensure early and accurate identification of allergies in pediatric patients, which is crucial for effective management and treatment. The growing incidence of allergic reactions is attributed to environmental factors, lifestyle changes, and genetic predispositions, driving the demand for comprehensive diagnostic solutions. The market is characterized by the presence of key players, including Thermo Fisher Scientific, Siemens Healthineers AG, and Eurofins Scientific,etc which are actively involved in research and development to introduce novel diagnostic tests. Strategic collaborations and partnerships among healthcare institutions, diagnostic laboratories, and technology providers are enhancing the accessibility and efficiency of allergy diagnostics. Regions such as North America and Europe hold significant market shares, driven by well-established healthcare infrastructure and a high awareness level regarding allergy-related issues.
Key Market Drivers
Increasing Prevalence of Allergic Conditions in Children
The increasing prevalence of allergic conditions in children, such as food allergies, asthma, and atopic dermatitis, is a significant factor driving the Global Pediatric Allergy Diagnostics Market. According to data from the American Academy of Allergy, Asthma and Immunology, a 2021 National Health Interview Survey (NHIS) revealed that more than a quarter of children (27.2%) have at least one allergic condition. This trend is influenced by various factors, including genetic predisposition, environmental changes, and lifestyle modifications. Genetic factors play a crucial role, as children with a family history of allergies are at a higher risk of developing similar conditions. Environmental influences, including urbanization, pollution, and changes in dietary patterns, contribute to the growing incidence of allergies. For instance, increased exposure to allergens like pollen, dust mites, mold, and specific foods can trigger allergic reactions, further complicating the landscape of pediatric health.
As awareness of the potential severity of allergic reactions rises among parents and caregivers, there is a growing demand for reliable diagnostic methods to identify specific allergens and effectively manage symptoms. This awareness is not only driven by the emotional distress caused by allergic conditions but also by the impact these allergies can have on a child’s quality of life, educational performance, and social interactions. In response to this need, healthcare providers are increasingly adopting advanced diagnostic techniques, including skin prick tests, blood tests, and molecular diagnostics, to facilitate early detection and intervention. The emphasis on proactive allergy management has led to an uptick in the development and adoption of comprehensive testing solutions. These innovations not only enable healthcare professionals to provide more accurate diagnoses but also empower families to make informed decisions regarding allergen avoidance and treatment strategies. As a result, the rising prevalence of allergic conditions in children significantly propels the growth of the pediatric allergy diagnostics market, reflecting an urgent need for improved health outcomes.
Advances in Diagnostic Technologies
Advances in diagnostic technologies are pivotal in shaping the Global Pediatric Allergy Diagnostics Market. Recent innovations in diagnostic tools, including skin prick tests, specific IgE tests, and component-resolved diagnostics, have fundamentally transformed the approach to allergy diagnosis in children. These advanced methodologies deliver precise and timely results, empowering healthcare providers to develop tailored treatment plans that address the unique needs of each child. Component-resolved diagnostics, in particular, represent a significant breakthrough. This technique allows clinicians to differentiate between genuine allergies and cross-reactive sensitizations, providing invaluable insights into a patient’s specific allergen triggers. By pinpointing the exact components of allergens that provoke reactions, clinicians can enhance their diagnostic accuracy and improve management strategies. This precision reduces unnecessary dietary restrictions and enhances the quality of life for affected children and their families.
The advent of point-of-care testing devices has markedly improved the accessibility of allergy diagnostics. These devices facilitate rapid testing in various healthcare settings, from pediatric clinics to emergency departments, ensuring timely interventions when allergies are suspected. The ability to obtain results quickly is crucial in pediatric care, where delayed diagnoses can lead to severe allergic reactions or chronic health issues. As these technologies continue to evolve and become more user-friendly, healthcare providers are increasingly inclined to adopt them, fueling market growth. The integration of mobile applications and telemedicine platforms with diagnostic devices further enhances accessibility, allowing parents to monitor their children’s allergies more effectively from home.
The ongoing investment in research and development by key players in the field accelerates the market's expansion. Innovations such as multiplex testing, which simultaneously measures multiple allergens, and artificial intelligence-driven diagnostics are on the horizon, promising to elevate diagnostic capabilities even further. These advancements not only improve the accuracy and efficiency of allergy testing but also empower healthcare providers and families to make informed decisions regarding allergy management and treatment, ultimately leading to better health outcomes for children.
Rising Demand for Personalized Medicine
The increasing focus on personalized medicine in pediatric healthcare is significantly propelling the growth of the Global Pediatric Allergy Diagnostics Market. This innovative approach prioritizes customizing medical treatments to align with the individual characteristics of each child, including their unique allergy profiles. By adopting personalized medicine, healthcare providers can develop tailored treatment plans that take into account a child's specific sensitivities, genetic predispositions, and risk factors for allergies. As a result, the role of accurate and comprehensive allergy diagnostics becomes paramount. Identifying specific allergens through advanced diagnostic tests is essential for informing treatment decisions and ensuring effective management of allergic conditions. For instance, through precise diagnostic methodologies, healthcare providers can pinpoint allergens responsible for a child’s symptoms, leading to targeted therapies that minimize adverse reactions and improve quality of life.
The growing awareness among parents and healthcare practitioners regarding the benefits of personalized healthcare is driving the demand for sophisticated allergy diagnostic tests. As the understanding of allergies evolves, there is a parallel increase in the availability of innovative diagnostic solutions that leverage cutting-edge technologies. This includes tests that utilize genomic and biomarker research to provide deeper insights into the underlying mechanisms of allergic reactions. Such advancements enable healthcare providers to deliver more precise and effective treatment options tailored to individual patients. As more research elucidates the complex nature of allergic diseases, personalized medicine is becoming integral to allergy management in pediatric patients. This trend highlights the necessity for robust diagnostic capabilities to facilitate effective allergy management, ensuring that each child receives optimal care based on their specific needs.
Key Market Challenges
High Cost of Advanced Diagnostic Technologies
The high cost associated with advanced diagnostic technologies presents a significant barrier to the growth of the Global Pediatric Allergy Diagnostics Market. While innovations in allergy diagnostics, such as molecular testing and immunoassays, have the potential to improve accuracy and efficiency, these technologies often come with substantial price tags. As a result, many healthcare facilities, particularly those in resource-limited settings, may struggle to afford these advanced tools. This financial constraint can limit access to effective allergy diagnostics for pediatric patients, especially in developing regions where healthcare budgets are tight. The high cost of diagnostic testing may deter parents from pursuing necessary evaluations for their children, leading to missed opportunities for timely diagnosis and intervention. To address this challenge, stakeholders in the healthcare industry, including manufacturers, policymakers, and healthcare providers, must work together to explore cost-effective solutions. This could involve developing affordable diagnostic technologies, implementing reimbursement policies that support diagnostic testing, and advocating for increased funding for allergy care in public health systems. By making advanced diagnostic tools more accessible and affordable, the market can ensure that all children receive the timely and accurate allergy assessments they need.
Limited Availability of Trained Healthcare Professionals
The Global Pediatric Allergy Diagnostics Market faces a challenge related to the limited availability of trained healthcare professionals specializing in allergy diagnostics and treatment. Allergies in children require a multidisciplinary approach involving allergists, pediatricians, and other healthcare providers who understand the complexities of allergic conditions. However, in many regions, there is a shortage of allergists and healthcare professionals trained to diagnose and manage allergies effectively. This scarcity can lead to long wait times for appointments, delaying critical diagnostic evaluations for pediatric patients. The lack of specialized training can result in inconsistent diagnostic practices among general practitioners, contributing to misdiagnosis or delayed treatment. The situation is particularly pronounced in rural and underserved areas, where access to specialized healthcare is limited. To address this challenge, there is a need for targeted education and training programs aimed at increasing the number of healthcare professionals proficient in allergy diagnostics. This could involve developing specialized training curricula for medical schools, offering continuing education opportunities for existing practitioners, and creating incentive programs to attract healthcare professionals to allergology. By bolstering the workforce with trained specialists, the market can enhance the quality of care for children suffering from allergies and improve diagnostic outcomes.
Key Market Trends
Expansion of Allergy Clinics and Testing Centers
The global expansion of allergy clinics and diagnostic testing centers is having a profound impact on the Global Pediatric Allergy Diagnostics Market. As these specialized healthcare facilities become more accessible, parents are increasingly able to seek timely and accurate allergy testing for their children. The establishment of dedicated clinics has created a streamlined approach to allergy care, offering a range of comprehensive services, including skin tests, blood tests, and consultations with experienced allergy specialists. This multi-faceted approach facilitates more precise diagnoses and tailored treatment plans, which are essential for effective allergy management in pediatric patients.
The proliferation of allergy clinics is primarily driven by the rising prevalence of allergies among children and the growing demand for specialized healthcare services. With allergies becoming more common in pediatric populations, the need for facilities equipped to handle these specific conditions has become critical. This trend is further supported by heightened awareness among parents regarding the importance of early diagnosis and intervention in managing allergies, prompting them to seek specialized care. On July 15, 2024, chemiluminescence immunoassays (ChLIA) play a crucial role in allergy diagnostics by enabling rapid and accurate identification of sensitizations to allergens. These assays facilitate the specific measurement of IgE antibodies in the blood, which are responsible for triggering allergic reactions. This capability is particularly significant in cases where traditional skin tests are challenging to administer due to underlying conditions or when results from other diagnostic methods are inconclusive, necessitating confirmation through alternative approaches.
Many allergy clinics are embracing advanced diagnostic technologies, which significantly enhance the quality of care provided to pediatric patients. These innovations include state-of-the-art testing methods that improve the accuracy of allergy diagnoses, allowing for more effective management strategies. For instance, the integration of molecular diagnostics can help identify specific allergens with greater precision, enabling healthcare providers to develop personalized treatment plans tailored to each child's unique needs. The expansion of allergy clinics not only benefits families seeking dedicated services for allergy management but also creates a favorable environment for allergy diagnostics overall. As more clinics and testing centers emerge, they contribute to increased competition, which often results in improved services and better patient outcomes.
Rising Incidence of Environmental Allergens
The increasing prevalence of environmental allergens—such as pollen, mold, dust mites, and pet dander—plays a significant role in driving the growth of the Global Pediatric Allergy Diagnostics Market. Factors like urbanization, climate change, and shifts in lifestyle have heightened exposure to these allergens, exacerbating allergic conditions among children. As urban areas expand and climates shift, the incidence of these allergens tends to rise, leading to a corresponding increase in allergic reactions and sensitivities in pediatric populations. As environmental allergens become more ubiquitous, the demand for effective diagnostic solutions intensifies. Parents and caregivers, increasingly aware of the impact of allergens on their children's health, are actively seeking precise diagnostic methods to identify specific allergens responsible for their child's symptoms. This heightened concern leads to greater emphasis on obtaining accurate diagnoses, which is crucial for developing effective treatment plans and managing allergic conditions.
In response to this growing demand, healthcare providers are integrating advanced diagnostic technologies into their practices. These innovations, which may include skin prick tests, blood tests, and molecular diagnostics, enable healthcare professionals to assess allergic sensitivities with greater accuracy. This precision in identifying allergens helps tailor interventions that effectively address the unique needs of each pediatric patient, enhancing the overall quality of care.
The increasing public awareness of the relationship between environmental factors and children's health further drives interest in allergy testing and management. Educational campaigns and community outreach initiatives have illuminated the significance of understanding and mitigating exposure to environmental allergens, leading to more families prioritizing allergy assessments. This rising awareness translates into a growing market for allergy diagnostics, as parents seek proactive measures to safeguard their children's health. Consequently, healthcare providers and clinics that offer specialized allergy services are experiencing increased demand, propelling the overall growth of the Global Pediatric Allergy Diagnostics Market. The rising incidence of environmental allergens is a critical factor influencing the market, prompting increased demand for advanced diagnostic solutions and effective management strategies tailored to the needs of children suffering from allergies.
Segmental Insights
Allergen Insights
Based on the Allergen, in the Global Pediatric Allergy Diagnostics Market, food allergens are currently dominating the sector, significantly influencing diagnosis and management strategies for allergic conditions in children. The rising prevalence of food allergies, particularly among pediatric populations, has led to increased awareness and concern among parents and healthcare providers. Common allergens, such as peanuts, tree nuts, dairy, eggs, and shellfish, are frequently implicated in allergic reactions, prompting parents to seek accurate diagnostic solutions. The demand for effective diagnostic tools to identify food allergens has surged as parents aim to ensure the safety of their children’s diets. This trend is further exacerbated by the potential severity of food allergies, which can lead to anaphylactic reactions, making timely and precise diagnosis critical. The increasing number of studies linking early introduction of certain foods to allergy prevention has also contributed to heightened awareness and testing.
Product Insights
Based on the product segment, In the Global Pediatric Allergy Diagnostics Market, instruments are currently dominating the sector, primarily due to the critical role they play in accurate and timely diagnosis of allergic conditions in children. This category includes various advanced diagnostic tools such as skin prick test devices, blood analyzers, and immunoassay kits. These instruments are essential for identifying specific allergens and determining the severity of allergic reactions, enabling healthcare providers to develop tailored treatment plans. The increasing prevalence of allergies among pediatric populations has driven the demand for sophisticated diagnostic instruments. As awareness of allergic conditions rises, healthcare facilities are investing in state-of-the-art equipment that can provide quick and reliable results. Technologies such as component-resolved diagnostics (CRD) and multiplex assays are gaining traction, allowing for simultaneous testing of multiple allergens and improving diagnostic efficiency.
Regional Insights
In the Global Pediatric Allergy Diagnostics Market, North America is currently the dominant region, primarily driven by high prevalence rates of allergic conditions among children, advanced healthcare infrastructure, and significant investment in research and development. The United States and Canada lead in the adoption of innovative diagnostic technologies, enhancing the accuracy and efficiency of allergy testing. Several factors contribute to North America's market dominance. The increasing incidence of allergies, including food allergies, asthma, and allergic rhinitis, has prompted heightened awareness among healthcare providers and parents. This rising awareness drives demand for accurate and timely diagnostic solutions to manage these conditions effectively. The presence of a well-established network of healthcare facilities, including specialized allergy clinics, further facilitates access to advanced diagnostic services for pediatric patients. North America benefits from robust regulatory support and the establishment of guidelines that promote best practices in allergy diagnosis and management. This regulatory framework encourages the adoption of cutting-edge diagnostic tools, including in vitro tests, which have gained popularity due to their non-invasive nature and reliability.
Key Market Players
• bioMérieux SA
• Thermo Fisher Scientific, Inc
• Stallergenes Greer
• Minaris Medical America Inc.
• Siemens Healthineers AG
• Cambridge Nutritional Sciences Plc(Omega Diagnostics Ltd)
• R-Biopharm AESKU.GROUP GmbH & Co. KG
• EUROIMMUN Medizinische Labordiagnostika AG
• HYCOR Biomedical
• Lincoln Diagnostics, Inc.
Report Scope:
In this report, the Global Pediatric Allergy Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Pediatric Allergy Diagnostics Market, By Allergen:
o Food
o Inhaled Drug
o Other Allergens
• Pediatric Allergy Diagnostics Market, By Product:
o Instruments
o Services
• Pediatric Allergy Diagnostics Market, By Test:
o In vivo Test
o In vitro Test
• Pediatric Allergy Diagnostics Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Allergy Diagnostics Market.
Available Customizations:
Global Pediatric Allergy Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).
ページTOPに戻る
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Pediatric Allergy Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Allergen (Food, Inhaled Drug, Other Allergens)
5.2.2. By Product (Instruments, Services)
5.2.3. By Test (In vivo Test, In vitro Test)
5.2.4. By Company (2023)
5.2.5. By Region
5.3. Market Map
6. North America Pediatric Allergy Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Allergen
6.2.2. By Product
6.2.3. By Test
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Pediatric Allergy Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Allergen
6.3.1.2.2. By Product
6.3.1.2.3. By Test
6.3.2. Mexico Pediatric Allergy Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Allergen
6.3.2.2.2. By Product
6.3.2.2.3. By Test
6.3.3. Canada Pediatric Allergy Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Allergen
6.3.3.2.2. By Product
6.3.3.2.3. By Test
7. Europe Pediatric Allergy Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Allergen
7.2.2. By Product
7.2.3. By Test
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Pediatric Allergy Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Allergen
7.3.1.2.2. By Product
7.3.1.2.3. By Test
7.3.2. Germany Pediatric Allergy Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Allergen
7.3.2.2.2. By Product
7.3.2.2.3. By Test
7.3.3. United Kingdom Pediatric Allergy Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Allergen
7.3.3.2.2. By Product
7.3.3.2.3. By Test
7.3.4. Italy Pediatric Allergy Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Allergen
7.3.4.2.2. By Product
7.3.4.2.3. By Test
7.3.5. Spain Pediatric Allergy Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Allergen
7.3.5.2.2. By Product
7.3.5.2.3. By Test
8. Asia-Pacific Pediatric Allergy Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Allergen
8.2.2. By Product
8.2.3. By Test
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pediatric Allergy Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Allergen
8.3.1.2.2. By Product
8.3.1.2.3. By Test
8.3.2. India Pediatric Allergy Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Allergen
8.3.2.2.2. By Product
8.3.2.2.3. By Test
8.3.3. South Korea Pediatric Allergy Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Allergen
8.3.3.2.2. By Product
8.3.3.2.3. By Test
8.3.4. Japan Pediatric Allergy Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Allergen
8.3.4.2.2. By Product
8.3.4.2.3. By Test
8.3.5. Australia Pediatric Allergy Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Allergen
8.3.5.2.2. By Product
8.3.5.2.3. By Test
9. South America Pediatric Allergy Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Allergen
9.2.2. By Product
9.2.3. By Test
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pediatric Allergy Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Allergen
9.3.1.2.2. By Product
9.3.1.2.3. By Test
9.3.2. Argentina Pediatric Allergy Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Allergen
9.3.2.2.2. By Product
9.3.2.2.3. By Test
9.3.3. Colombia Pediatric Allergy Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Allergen
9.3.3.2.2. By Product
9.3.3.2.3. By Test
10. Middle East and Africa Pediatric Allergy Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Allergen
10.2.2. By Product
10.2.3. By Test
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pediatric Allergy Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Allergen
10.3.1.2.2. By Product
10.3.1.2.3. By Test
10.3.2. Saudi Arabia Pediatric Allergy Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Allergen
10.3.2.2.2. By Product
10.3.2.2.3. By Test
10.3.3. UAE Pediatric Allergy Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Allergen
10.3.3.2.2. By Product
10.3.3.2.3. By Test
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. bioMérieux SA
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Thermo Fisher Scientific, Inc
14.3. Stallergenes Greer
14.4. Minaris Medical America Inc.
14.5. Siemens Healthineers AG
14.6. Cambridge Nutritional Sciences Plc(Omega Diagnostics Ltd)
14.7. R-Biopharm AESKU.GROUP GmbH & Co. KG
14.8. EUROIMMUN Medizinische Labordiagnostika AG
14.9. HYCOR Biomedical
14.10. Lincoln Diagnostics, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
